Article Text

Download PDFPDF
Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease
  1. M C Collado1,
  2. E Donat2,
  3. C Ribes-Koninckx2,
  4. M Calabuig3,
  5. Y Sanz1
  1. 1Microbial Ecophysiology and Nutrition Group, Instituto de Agroquímica y Tecnología de Alimentos (CSIC), Valencia, Spain
  2. 2Hospital Universitario La Fe, Valencia, Spain
  3. 3Hospital General Universitario, Valencia, Spain
  1. Dr Y Sanz, Instituto de Agroquímica y Tecnología de Alimentos (CSIC), PO Box 73, 46100 Burjassot, Valencia, Spain; yolsanz{at}


Aims: To identify specific gut bacteria associated with coeliac disease (CD) at diagnosis and after treatment with a gluten-free diet (GFD) in a paediatric population.

Methods: 30 and 18 faecal samples from untreated and treated CD patients and 25 and 8 biopsy samples from untreated and treated CD patients, respectively, were analysed. In addition, 30 faecal and 8 biopsy samples from control children were evaluated for comparative purposes. Gut bacterial groups were quantified by real-time PCR.

Results: Bacteroides and Clostridium leptum groups were more abundant in faeces and biopsies of CD patients than in controls regardless of the stage of the disease. E coli and Staphylococcus counts were also higher in faeces and biopsies of non-treated CD patients than in those of controls, but their levels were normalised after treatment with a GFD. Bifidobacterium levels were lower in faeces of both groups of CD patients and in biopsies of untreated CD patients compared to controls. Similar bacterial groups were related to CD in biopsies and faeces, indicating that faecal microbiota partly reflects that of the small intestine in CD patients, and could constitute a convenient biological index of this disorder.

Conclusions: Duodenal and faecal microbiota is unbalanced in children with untreated CD and only partially restored after long-term treatment with a GFD, constituting a novel factor linked to this disorder.

Statistics from


  • Funding: This work was supported by grants AGL-2005-05788-C02-01 and Consolider Fun-C-Food CSD2007-00063 from the Spanish Ministry of Science and Innovation. I3P-CSIC Postdoctoral Contract from the European Social Fund to MCC is fully acknowledged.

  • Competing interests: None.

  • Ethics approval: Ethics approval was obtained from the ethics committee of CSIC and the hospitals taking part in the study (Hospital Universitario La Fe and Hospital General Universitario, Valencia, Spain).

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.